These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34654049)

  • 21. SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association.
    Jone PN; John A; Oster ME; Allen K; Tremoulet AH; Saarel EV; Lambert LM; Miyamoto SD; de Ferranti SD;
    Circulation; 2022 May; 145(19):e1037-e1052. PubMed ID: 35400169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.
    Hanson BA; Visvabharathy L; Ali ST; Kang AK; Patel TR; Clark JR; Lim PH; Orban ZS; Hwang SS; Mattoon D; Batra A; Liotta EM; Koralnik IJ
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35256481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complications of severe acute respiratory syndrome coronavirus 2 infection in children.
    Caorsi R; Civino A; Ravelli A
    Curr Opin Rheumatol; 2022 Sep; 34(5):267-273. PubMed ID: 35797144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of the COVID-19 pandemic on the field of pediatric rheumatology.
    Wahezi DM; Peskin M; Tanner T
    Curr Opin Rheumatol; 2021 Sep; 33(5):446-452. PubMed ID: 34175864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurologic aspects of coronavirus disease of 2019 infection.
    Hassett CE; Frontera JA
    Curr Opin Infect Dis; 2021 Jun; 34(3):217-227. PubMed ID: 33769966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Approaches to the Neurologic Manifestations of COVID-19.
    Graham EL; Koralnik IJ; Liotta EM
    Neurotherapeutics; 2022 Sep; 19(5):1435-1466. PubMed ID: 35861926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis.
    Wang L; Shen Y; Li M; Chuang H; Ye Y; Zhao H; Wang H
    J Neurol; 2020 Oct; 267(10):2777-2789. PubMed ID: 32529575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous manifestations in children with SARS-CoV-2 infection and/or COVID-19: what do we know after 10 months under this pandemic?
    Li H; Zhao Y; Zhou L
    Int J Dermatol; 2022 Jan; 61(1):39-45. PubMed ID: 34530491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study.
    Lindan CE; Mankad K; Ram D; Kociolek LK; Silvera VM; Boddaert N; Stivaros SM; Palasis S;
    Lancet Child Adolesc Health; 2021 Mar; 5(3):167-177. PubMed ID: 33338439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hide and seek in a pandemic: review of SARS-CoV-2 infection and sequelae in children.
    Clark JA; Pathan N
    Exp Physiol; 2022 Jul; 107(7):653-664. PubMed ID: 34242467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system outcomes of COVID-19.
    Doyle MF
    Transl Res; 2022 Mar; 241():41-51. PubMed ID: 34601116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal and hepatic involvement during COVID-19 pandemic: A focus on pediatric population and possible future implications.
    Sica R; Pennoni S; Penta L; Riccioni S; Di Cara G; Verrotti A
    World J Gastroenterol; 2021 Oct; 27(40):7000-7004. PubMed ID: 34790020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Features of neurological manifestations of the COVID-19 in children and adults].
    Kholin AA; Zavadenko NN; Nesterovskiy YE; Kholina EA; Zavadenko AN; Khondkaryan GS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(9):114-120. PubMed ID: 33081456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis.
    Prakash A; Singh H; Sarma P; Bhattacharyya A; Dhibar DP; Balaini N; Shree R; Goyal M; Modi M; Medhi B
    Sci Rep; 2021 Jun; 11(1):12888. PubMed ID: 34145351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
    Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
    J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review.
    Panigrahy N; Policarpio J; Ramanathan R
    J Pediatr Rehabil Med; 2020; 13(3):301-316. PubMed ID: 33252101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multisystem Inflammatory Syndrome in Children (MIS-C).
    Patel JM
    Curr Allergy Asthma Rep; 2022 May; 22(5):53-60. PubMed ID: 35314921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.